Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CHRO

Chromocell Therapeutics (CHRO) Stock Price, News & Analysis

Chromocell Therapeutics logo

About Chromocell Therapeutics Stock (NYSE:CHRO)

Advanced Chart

Key Stats

Today's Range
$1.23
$1.48
50-Day Range
$1.34
$13.50
52-Week Range
$4.50
$38.00
Volume
194,032 shs
Average Volume
47,337 shs
Market Capitalization
$8.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CHRO Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Ligand subsidiaries, Chromocell Therapeutics to merge
Chromocell Therapeutics Corp (CHRO)
Channel Therapeutics Corporation (CHRO)
See More Headlines

CHRO Stock Analysis - Frequently Asked Questions

Shares of Chromocell Therapeutics reverse split on the morning of Wednesday, July 2nd 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Chromocell Therapeutics (CHRO) raised $7 million in an initial public offering (IPO) on Friday, February 16th 2024. The company issued 1,100,000 shares at $6.00 per share.

Company Calendar

Today
8/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CHRO
Previous Symbol
NYSE:CHRO
CIK
1919246
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.38 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-453.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.60

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.65) per share
Price / Book
-0.81

Miscellaneous

Outstanding Shares
6,485,000
Free Float
5,039,000
Market Cap
$8.69 million
Optionable
N/A
Beta
3.63

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:CHRO) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners